694 related articles for article (PubMed ID: 24837215)
1. Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial.
Jeong SY; Park JW; Nam BH; Kim S; Kang SB; Lim SB; Choi HS; Kim DW; Chang HJ; Kim DY; Jung KH; Kim TY; Kang GH; Chie EK; Kim SY; Sohn DK; Kim DH; Kim JS; Lee HS; Kim JH; Oh JH
Lancet Oncol; 2014 Jun; 15(7):767-74. PubMed ID: 24837215
[TBL] [Abstract][Full Text] [Related]
2. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): 10-year follow-up of an open-label, non-inferiority, randomised controlled trial.
Park JW; Kang SB; Hao J; Lim SB; Choi HS; Kim DW; Chang HJ; Kim DY; Jung KH; Kim TY; Kang GH; Chie EK; Kim SY; Sohn DK; Kim JS; Lee HS; Kim JH; Jeong SY; Oh JH
Lancet Gastroenterol Hepatol; 2021 Jul; 6(7):569-577. PubMed ID: 33894918
[TBL] [Abstract][Full Text] [Related]
3. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial.
Kang SB; Park JW; Jeong SY; Nam BH; Choi HS; Kim DW; Lim SB; Lee TG; Kim DY; Kim JS; Chang HJ; Lee HS; Kim SY; Jung KH; Hong YS; Kim JH; Sohn DK; Kim DH; Oh JH
Lancet Oncol; 2010 Jul; 11(7):637-45. PubMed ID: 20610322
[TBL] [Abstract][Full Text] [Related]
4. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
5. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.
Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358
[TBL] [Abstract][Full Text] [Related]
6. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial.
van der Pas MH; Haglind E; Cuesta MA; Fürst A; Lacy AM; Hop WC; Bonjer HJ;
Lancet Oncol; 2013 Mar; 14(3):210-8. PubMed ID: 23395398
[TBL] [Abstract][Full Text] [Related]
7. The Effectiveness and Safety of Open Versus laparoscopic Surgery for Rectal Cancer after Preoperative Chemo-radiotherapy: A Meta-Analysis.
Zhang JJ; Guo BL; Zheng QX; Chen ZY
Comb Chem High Throughput Screen; 2019; 22(3):153-159. PubMed ID: 30987563
[TBL] [Abstract][Full Text] [Related]
8. Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial.
; Buunen M; Veldkamp R; Hop WC; Kuhry E; Jeekel J; Haglind E; Påhlman L; Cuesta MA; Msika S; Morino M; Lacy A; Bonjer HJ
Lancet Oncol; 2009 Jan; 10(1):44-52. PubMed ID: 19071061
[TBL] [Abstract][Full Text] [Related]
9. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
[TBL] [Abstract][Full Text] [Related]
10. Survival outcomes following laparoscopic versus open D3 dissection for stage II or III colon cancer (JCOG0404): a phase 3, randomised controlled trial.
Kitano S; Inomata M; Mizusawa J; Katayama H; Watanabe M; Yamamoto S; Ito M; Saito S; Fujii S; Konishi F; Saida Y; Hasegawa H; Akagi T; Sugihara K; Yamaguchi T; Masaki T; Fukunaga Y; Murata K; Okajima M; Moriya Y; Shimada Y
Lancet Gastroenterol Hepatol; 2017 Apr; 2(4):261-268. PubMed ID: 28404155
[TBL] [Abstract][Full Text] [Related]
11. Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short-term outcomes of a multicentre randomised controlled trial.
Feng Q; Yuan W; Li T; Tang B; Jia B; Zhou Y; Zhang W; Zhao R; Zhang C; Cheng L; Zhang X; Liang F; He G; Wei Y; Xu J;
Lancet Gastroenterol Hepatol; 2022 Nov; 7(11):991-1004. PubMed ID: 36087608
[TBL] [Abstract][Full Text] [Related]
12. Short-term outcomes of laparoscopically assisted surgery for rectal cancer following neoadjuvant chemoradiotherapy: a single-center experience.
Hu JJ; Liang JW; Wang Z; Zhang XM; Zhou HT; Hou HR; Zhou ZX
J Surg Res; 2014 Apr; 187(2):438-44. PubMed ID: 24252856
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the efficacy of laparoscopic surgery in treatment of advanced mid-low rectal cancer following a long-term neoadjuvant chemoradiotherapy].
Ge L; Lei C; He D; Sun ZQ; Wang QS; Zhao WM; Wang HJ
Zhonghua Yi Xue Za Zhi; 2016 Sep; 96(34):2709-2712. PubMed ID: 27667102
[No Abstract] [Full Text] [Related]
14. Laparoscopic versus open surgery for rectal cancer after neoadjuvant chemoradiation: Long-term outcomes of a propensity score matched study.
Seshadri RA; Swaminathan R; Srinivasan A
J Surg Oncol; 2018 Mar; 117(3):506-513. PubMed ID: 29044538
[TBL] [Abstract][Full Text] [Related]
15. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial.
Rödel C; Liersch T; Becker H; Fietkau R; Hohenberger W; Hothorn T; Graeven U; Arnold D; Lang-Welzenbach M; Raab HR; Sülberg H; Wittekind C; Potapov S; Staib L; Hess C; Weigang-Köhler K; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R;
Lancet Oncol; 2012 Jul; 13(7):679-87. PubMed ID: 22627104
[TBL] [Abstract][Full Text] [Related]
16. Prognosis Comparisons of Laparoscopy versus Open Surgery for Rectal Cancer Patients after Preoperative Chemoradiotherapy: A Meta-Analysis.
Niu JW; Ning W; Liu ZZ; Pei DP; Meng FQ; Zhou L
Oncol Res Treat; 2021; 44(5):261-268. PubMed ID: 33910201
[TBL] [Abstract][Full Text] [Related]
17. Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial.
Rullier E; Rouanet P; Tuech JJ; Valverde A; Lelong B; Rivoire M; Faucheron JL; Jafari M; Portier G; Meunier B; Sileznieff I; Prudhomme M; Marchal F; Pocard M; Pezet D; Rullier A; Vendrely V; Denost Q; Asselineau J; Doussau A
Lancet; 2017 Jul; 390(10093):469-479. PubMed ID: 28601342
[TBL] [Abstract][Full Text] [Related]
18. Long-term Outcomes of Laparoscopic versus Open Surgery for Rectal Cancer: A Single-center Retrospective Analysis.
Kim JH; Ahn BK; Park SJ; Park MI; Kim SE; Baek SU; Lee SH; Park SS
Korean J Gastroenterol; 2015 May; 65(5):273-82. PubMed ID: 25998973
[TBL] [Abstract][Full Text] [Related]
19. Laparoscopic surgery is feasible for the treatment of rectal cancer after neoadjuvant chemoradiotherapy.
Ju W; Luo X; Han B
Pak J Pharm Sci; 2016 Sep; 29(5 Suppl):1817-1821. PubMed ID: 28476708
[TBL] [Abstract][Full Text] [Related]
20. Short- and long-term outcome following laparoscopic versus open resection for carcinoma of the rectum in the multimodal setting.
Kellokumpu IH; Kairaluoma MI; Nuorva KP; Kautiainen HJ; Jantunen IT
Dis Colon Rectum; 2012 Aug; 55(8):854-63. PubMed ID: 22810470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
